Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Hair transplant can cause hard-to-treat keloids in some patients.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

New drug delivery systems improve treatment effectiveness and patient experience.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Sorafenib may cause hair loss in a way similar to alopecia areata.

The herbal preparation may help manage alopecia by reducing inflammation and boosting the immune response.

Some medications can cause reversible hair loss by affecting hair growth cycles.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

ILC1 cells contribute to hair loss in alopecia areata.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Immune system failure in hair follicles causes lichen planopilaris, leading to hair loss.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.